Molecular clues assist in the cancer clinic

Science Translational Medicine

Volumn 5, Issue 193, 2013, Pages

  Tomlins, Scott A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETS;

ALGORITHM; ARTICLE; BIOINFORMATICS; CASTRATION RESISTANT PROSTATE CANCER; ETS GENE; ETS RELATED GENE; ETS VARIANT 1 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; TMPRSS2 GENE;

AWARDS AND PRIZES; COMPUTATIONAL BIOLOGY; GENES, NEOPLASM; HEALTH FACILITIES; HUMANS; MALE; PROSTATIC NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84880562897     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006642     Document Type: Article

References (10)

1. S. A. Tomlins, D. R. Rhodes, S. Perner, S. M. Dhanasekaran, R. Mehra, X. W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J. E. Montie, R. B. Shah, K. J. Pienta, M. A. Rubin, A. M. Chinnaiyan, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648 (2005). (Pubitemid 41528150)
2. S. A. Tomlins, B. Laxman, S. M. Dhanasekaran, B. E. Helgeson, X. Cao, D. S.Morris, A.Menon, X. Jing, Q. Cao, B. Han, J. Yu, L. Wang, J. E. Montie, M. A. Rubin, K. J. Pienta, D. Roulston, R. B. Shah, S. Varambally, R. Mehra, A. M. Chinnaiyan, Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595-599 (2007). (Pubitemid 47206938)
3. R. B. Shah, Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management. Adv. Anat. Pathol. 20, 117-124 (2013).
4. S. A. Tomlins, N. Palanisamy, J. Siddiqui, A. M. Chinnaiyan, L. P. Kunju, Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. Arch. Pathol. Lab. Med. 136, 935-946 (2012).
5. S. A. Tomlins, S. M. Aubin, J. Siddiqui, R. J. Lonigro, L. Sefton-Miller, S. Miick, S. Williamsen, P. Hodge, J. Meinke, A. Blase, Y. Penabella, J. R. Day, R. Varambally, B. Han, D. Wood, L. Wang, M. G. Sanda, M. A. Rubin, D. R. Rhodes, B. Hollenbeck, K. Sakamoto, J. L. Silberstein, Y. Fradet, J. B. Amberson, S. Meyers, N. Palanisamy, H. Rittenhouse, J. T. Wei, J. Groskopf, A. M. Chinnaiyan, Urine TMPRSS2:ERG fusion transcript stratifi es prostate cancer risk in men with elevated serum PSA. Sci. Transl. Med. 3, 94ra72 (2011).
6. + and total prostate cancer burden. Am. J. Clin. Pathol. 138, 685-696 (2012).
7. S. A. Tomlins, D. R. Rhodes, J. Yu, S. Varambally, R. Mehra, S. Perner, F. Demichelis, B. E. Helgeson, B. Laxman, D. S. Morris, Q. Cao, X. Cao, O. Andrén, K. Fall, L. Johnson, J. T. Wei, R. B. Shah, H. Al-Ahmadie, J. A. Eastham, S. E. Eggener, S. W. Fine, K. Hotakainen, U. H. Stenman, A. Tsodikov, W. L. Gerald, H. Lilja, V. E. Reuter, P. W. Kantoff, P. T. Scardino, M. A. Rubin, A. S. Bjartell, A. M. Chinnaiyan, The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell 13, 519-528 (2008). (Pubitemid 351763901)
8. C. S. Grasso, Y. M. Wu, D. R. Robinson, X. Cao, S. M. Dhanasekaran, A. P. Khan, M. J. Quist, X. Jing, R. J. Lonigro, J. C. Brenner, I. A. Asangani, B. Ateeq, S. Y. Chun, J. Siddiqui, L. Sam, M. Anstett, R. Mehra, J. R. Prensner, N. Palanisamy, G. A. Ryslik, F. Vandin, B. J. Raphael, L. P. Kunju, D. R. Rhodes, K. J. Pienta, A. M. Chinnaiyan, S. A. Tomlins, The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243 (2012).
9. S. C. Baca, D. Prandi, M. S. Lawrence, J. M. Mosquera, A. Romanel, Y. Drier, K. Park, N. Kitabayashi, T. Y. MacDonald, M. Ghandi, E. Van Allen, G. V. Kryukov, A. Sboner, J. P. Theurillat, T. D. Soong, E. Nickerson, D. Auclair, A. Tewari, H. Beltran, R. C. Onofrio, G. Boysen, C. Guiducci, C. E. Barbieri, K. Cibulskis, A. Sivachenko, S. L. Carter, G. Saksena, D. Voet, A. H. Ramos, W. Winckler, M. Cipicchio, K. Ardlie, P. W. Kantoff, M. F. Berger, S. B. Gabriel, T. R. Golub, M. Meyerson, E. S. Lander, O. Elemento, G. Getz, F. Demichelis, M. A. Rubin, L. A. Garraway, Punctuated evolution of prostate cancer genomes. Cell 153, 666-677 (2013).
10. C. E. Barbieri, S. C. Baca, M. S. Lawrence, F. Demichelis, M. Blattner, J. P. Theurillat, T. A. White, P. Stojanov, E. Van Allen, N. Stransky, E. Nickerson, S. S. Chae, G. Boysen, D. Auclair, R. C. Onofrio, K. Park, N. Kitabayashi, T. Y. MacDonald, K. Sheikh, T. Vuong, C. Guiducci, K. Cibulskis, A. Sivachenko, S. L. Carter, G. Saksena, D. Voet, W. M. Hussain, A. H. Ramos, W. Winckler, M. C. Redman, K. Ardlie, A. K. Tewari, J. M. Mosquera, N. Rupp, P. J. Wild, H. Moch, C. Morrissey, P. S. Nelson, P. W. Kantoff, S. B. Gabriel, T. R. Golub, M. Meyerson, E. S. Lander, G. Getz, M. A. Rubin, L. A. Garraway, Exome sequencing identifi es recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).